Jane Street

Jane Street Portfolio holdings

AUM $62B
1-Year Return 4.11%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Quarter Return
+0.61%
1 Year Return
+4.11%
3 Year Return
+15.25%
5 Year Return
+21.47%
10 Year Return
+49.61%
AUM
$51.9B
AUM Growth
+$12.3B
Cap. Flow
+$11.1B
Cap. Flow %
21.46%
Top 10 Hldgs %
25.43%
Holding
6,396
New
1,138
Increased
2,139
Reduced
1,788
Closed
1,019

Sector Composition

1 Technology 17.07%
2 Consumer Discretionary 13.49%
3 Financials 7.29%
4 Communication Services 6.66%
5 Healthcare 4.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
UTHR icon
3476
United Therapeutics
UTHR
$18B
$486K ﹤0.01%
2,249
-28,915
-93% -$6.25M
SV
3477
DELISTED
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
$486K ﹤0.01%
+48,512
New +$486K
AGRO icon
3478
Adecoagro
AGRO
$822M
$485K ﹤0.01%
+63,104
New +$485K
RAYC icon
3479
Rayliant Quantamental China Equity ETF
RAYC
$21.1M
$485K ﹤0.01%
+19,037
New +$485K
RVNC
3480
DELISTED
Revance Therapeutics, Inc.
RVNC
$485K ﹤0.01%
29,700
-6,261
-17% -$102K
ELS icon
3481
Equity Lifestyle Properties
ELS
$11.8B
$484K ﹤0.01%
5,518
-36,917
-87% -$3.24M
USFD icon
3482
US Foods
USFD
$17.5B
$484K ﹤0.01%
13,916
-26,192
-65% -$911K
GOBI
3483
DELISTED
Gobi Acquisition Corp. Class A Ordinary Shares
GOBI
$484K ﹤0.01%
50,078
+78
+0.2% +$754
ARRWU
3484
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
$483K ﹤0.01%
48,461
-19
-0% -$189
FJP icon
3485
First Trust Japan AlphaDEX Fund
FJP
$204M
$482K ﹤0.01%
9,674
-7,867
-45% -$392K
ST icon
3486
Sensata Technologies
ST
$4.61B
$482K ﹤0.01%
7,817
-8,589
-52% -$530K
VWID icon
3487
Virtus WMC International Dividend ETF
VWID
$13.6M
$482K ﹤0.01%
17,576
-9,034
-34% -$248K
EDTX
3488
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
$482K ﹤0.01%
48,083
+16
+0% +$160
FLCA icon
3489
Franklin FTSE Canada ETF
FLCA
$472M
$481K ﹤0.01%
13,931
-18,040
-56% -$623K
BFAM icon
3490
Bright Horizons
BFAM
$6.28B
$480K ﹤0.01%
3,806
-358,175
-99% -$45.2M
RGNX icon
3491
Regenxbio
RGNX
$468M
$480K ﹤0.01%
14,694
+7,445
+103% +$243K
EPZM
3492
DELISTED
Epizyme, Inc
EPZM
$480K ﹤0.01%
192,280
+86,745
+82% +$217K
SGMO icon
3493
Sangamo Therapeutics
SGMO
$155M
$479K ﹤0.01%
63,833
+30,337
+91% +$228K
AIQ icon
3494
Global X Artificial Intelligence & Technology ETF
AIQ
$5.02B
$478K ﹤0.01%
15,032
-29,541
-66% -$939K
ARVN icon
3495
Arvinas
ARVN
$561M
$478K ﹤0.01%
5,821
+223
+4% +$18.3K
EMMF icon
3496
WisdomTree Emerging Markets Multifactor Fund
EMMF
$126M
$478K ﹤0.01%
19,137
-74,465
-80% -$1.86M
CUTR
3497
DELISTED
Cutera, Inc.
CUTR
$478K ﹤0.01%
11,558
-31,215
-73% -$1.29M
FFIC icon
3498
Flushing Financial
FFIC
$469M
$477K ﹤0.01%
19,645
+4,931
+34% +$120K
SNDX icon
3499
Syndax Pharmaceuticals
SNDX
$1.3B
$477K ﹤0.01%
+21,778
New +$477K
BTAI icon
3500
BioXcel Therapeutics
BTAI
$47.9M
$476K ﹤0.01%
1,465
+830
+131% +$270K